Wendell W. Weber
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 13
- Cancer Research top 1%
- Carcinogens and Genotoxicity Assessment 17
- Biochemistry top 1%
- Pharmaceutical Science top 2%
- Chemical Reactions and Isotopes 14
- Molecular Biology top 5%
- Polyamine Metabolism and Applications 18
- Epigenetics and DNA Methylation 13
- Genomics, phytochemicals, and oxidative stress 8
-
- Pancreatic function and diabetes 10
-
- Metabolism and Genetic Disorders 8
- Co-authors
- David W. HeinKostas P. VatsisGerald N. LevyIrene B. GlowinskiK J MartellSanford N. CohenD. J. HearseHerbert Andres
- Journals
- Drug Metabolism and Disposition (19 papers)Molecular Pharmacology (10 papers)Journal of Pharmacology and Experimental Therapeutics (9 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Wendell W. Weber
119 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Pharmacology 683
- Cancer Research 1.1k
- Biochemistry 459
- Pharmaceutical Science 217
- Molecular Biology 2.3k
Countries citing papers authored by Wendell W. Weber
This map shows the geographic impact of Wendell W. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendell W. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendell W. Weber more than expected).
Fields of papers citing papers by Wendell W. Weber
This network shows the impact of papers produced by Wendell W. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendell W. Weber. The network helps show where Wendell W. Weber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wendell W. Weber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PrefaceWerner Kalow Commemorative IssueAspet/aacc ConferenceNew Directions in Pharmacogenetics and EcogeneticsGenetic Defenses Against Environmental ImpactsResponses to Infections, Foods, and Environmental Toxicants | 2001 | 1 |
| 2 | 2001 | 3 | |
| 3 | 2001 | 18 | |
| 4 | 2001 | 11 | |
| 5 | 2000 | 46 | |
| 6 | 1995 | 22 | |
| 7 | 1995 | 318 | |
| 8 | 1994 | 26 | |
| 9 | 1993 | 3 | |
| 10 | 1993 | 54 | |
| 11 | 1992 | 18 | |
| 12 | 1991 | 15 | |
| 13 | 1990 | 34 | |
| 14 | 1989 | 32 | |
| 15 | Michaelis menten constants for arylamine drugs in rapid and slow human acetylator liver | 1988 | 2 |
| 16 | N-acetylation pharmacogenetics.breakdown → | 1985 | 533 |
| 17 | 1982 | 5 | |
| 18 | 1982 | 33 | |
| 19 | 1981 | 25 | |
| 20 | 1979 | 17 |
About Wendell W. Weber
Wendell W. Weber is a scholar working on Pharmaceutical Science, Cancer Research and Pharmacology, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include Polyamine Metabolism and Applications (18 papers), Carcinogens and Genotoxicity Assessment (17 papers), Chemical Reactions and Isotopes (14 papers), Pharmacogenetics and Drug Metabolism (13 papers), Epigenetics and DNA Methylation (13 papers), Pancreatic function and diabetes (10 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Metabolism and Genetic Disorders (8 papers). The work is most often cited by research in Pharmacology (683 citations), Cancer Research (1.1k citations) and Biochemistry (459 citations). Wendell W. Weber has collaborated with scholars based in United States, China and France. Frequent co-authors include David W. Hein, Kostas P. Vatsis, Gerald N. Levy, Irene B. Glowinski, K J Martell, Sanford N. Cohen, D. J. Hearse, Herbert Andres, Denis M. Grant and Jing‐Gung Chung. Their work appears in journals such as Drug Metabolism and Disposition, Molecular Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Carcinogenesis and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.